Unknown

Dataset Information

0

Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome.


ABSTRACT: Germline mutations are responsible for familial cancer syndromes which account for approximately 5-10% of all types of cancers. These mutations mainly occur at tumor suppressor genes or genome stability genes, such as DNA repair genes. Here we have identified a cancer predisposition family, in which eight members were inflicted with a wide spectrum of cancer including one diagnosed with lung cancer at 22years old. Sequencing analysis of tumor samples as well as histologically normal specimens identified two germline mutations co-existing in the familial cancer syndrome, the mutation of tumor suppressor gene P53 V157D and mismatch repair gene PMS2 R20Q. We further demonstrate that P53 V157D and/or PMS2 R20Q mutant promotes lung cancer cell proliferation. These two mutants are capable of promoting colony formation in soft agar as well as tumor formation in transgenic drosophila system. Collectively, these data have uncovered the important role of co-existing germline P53 and PMS2 mutations in the familial cancer syndrome development.

SUBMITTER: Wang Z 

PROVIDER: S-EPMC3981830 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome.

Wang Zuoyun Z   Sun Yihua Y   Gao Bin B   Lu Yi Y   Fang Rong R   Gao Yijun Y   Xiao Tian T   Liu Xin-Yuan XY   Pao William W   Zhao Yun Y   Chen Haiquan H   Ji Hongbin H  

Cancer letters 20130824 1


Germline mutations are responsible for familial cancer syndromes which account for approximately 5-10% of all types of cancers. These mutations mainly occur at tumor suppressor genes or genome stability genes, such as DNA repair genes. Here we have identified a cancer predisposition family, in which eight members were inflicted with a wide spectrum of cancer including one diagnosed with lung cancer at 22years old. Sequencing analysis of tumor samples as well as histologically normal specimens id  ...[more]

Similar Datasets

| S-EPMC8741038 | biostudies-literature
2021-12-13 | GSE184499 | GEO
2021-12-13 | GSE184498 | GEO
2021-12-13 | GSE167275 | GEO
| PRJNA764781 | ENA
| PRJNA704060 | ENA
| PRJNA764783 | ENA
| S-EPMC3874239 | biostudies-literature
| S-EPMC6565568 | biostudies-literature
| S-EPMC5995637 | biostudies-literature